Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study

An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)

(2012) Shigeru Nakai et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Erythropoiesis-Stimulating Agent Responsiveness and Mortality in Hemodialysis Patients: Results from a Cohort Study From the Dialysis Registry in Japan

(2011) Shingo Fukuma et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Relationship between erythropoietin resistance index and left ventricular mass and function and cardiovascular events in patients on chronic hemodialysis

(2011) Sungjin Chung et al.   Hemodialysis International

Relationship Between Erythropoietin Responsiveness, Insulin Resistance, and Malnutrition-Inflammation-Atherosclerosis (Mia) Syndrome in Hemodialysis Patients with Diabetes

(2011) Masanori Abe et al.   INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS

Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin

(2010) Takeshi Hasegawa et al.   KIDNEY INTERNATIONAL

Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients

(2009) Kamyar Kalantar-Zadeh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment

(2009) Lynda A. Szczech et al.   KIDNEY INTERNATIONAL

Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients

(2008) R. D. Kilpatrick et al.   Clinical Journal of the American Society of Nephrology

Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes

(2008) Lynda A. Szczech et al.   KIDNEY INTERNATIONAL

Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS

(2008) T. Akizawa et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION